Literature DB >> 12003966

In vitro susceptibilities of Zygomycota to polyenes.

Eric Dannaoui1, Jacques F G M Meis, Johan W Mouton, Paul E Verweij.   

Abstract

The in vitro activity of polyenes was determined for 36 isolates of Zygomycota including Rhizopus spp. (15), Absidia corymbifera (10), Mucor spp. (6), Rhizomucor spp. (3), Cunninghamella bertholletiae (1) and Apophysomyces elegans (1). All isolates were tested with amphotericin B, heated amphotericin B and nystatin by a broth microdilution test. There were no significant differences between heated and unheated solutions of amphotericin B in terms of their antifungal activities. The MICs of amphotericin B for most of the strains were <2 mg/L. For all isolates, nystatin was significantly less active than amphotericin B (P < 0.001). The one C. bertholletiae and one A. elegans isolates were less susceptible to amphotericin B (MICs 2 mg/L) and were also less susceptible to nystatin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12003966     DOI: 10.1093/jac/dkf012

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  8 in total

1.  Antifungal susceptibility and phylogeny of opportunistic members of the order mucorales.

Authors:  Roxana G Vitale; G Sybren de Hoog; Patrick Schwarz; Eric Dannaoui; Shuwen Deng; Marie Machouart; Kerstin Voigt; Wendy W J van de Sande; Somayeh Dolatabadi; Jacques F Meis; Grit Walther
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

Review 2.  Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.

Authors:  M A Pfaller; D J Diekema
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

Review 3.  Sequence-based identification of Aspergillus, fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here?

Authors:  S A Balajee; A M Borman; M E Brandt; J Cano; M Cuenca-Estrella; E Dannaoui; J Guarro; G Haase; C C Kibbler; W Meyer; K O'Donnell; C A Petti; J L Rodriguez-Tudela; D Sutton; A Velegraki; B L Wickes
Journal:  J Clin Microbiol       Date:  2008-12-10       Impact factor: 5.948

Review 4.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

5.  Molecular detection and identification of zygomycetes species from paraffin-embedded tissues in a murine model of disseminated zygomycosis: a collaborative European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) evaluation.

Authors:  Eric Dannaoui; Patrick Schwarz; Michal Slany; Juergen Loeffler; Anne Tomine Jorde; Manuel Cuenca-Estrella; Philippe M Hauser; Raghdaa Shrief; Michel Huerre; Tomas Freiberger; Peter Gaustad; Juan-Luis Rodriguez-Tudela; Jacques Bille; David W Denning; Stéphane Bretagne; Olivier Lortholary
Journal:  J Clin Microbiol       Date:  2010-04-07       Impact factor: 5.948

6.  Molecular identification of zygomycetes from culture and experimentally infected tissues.

Authors:  Patrick Schwarz; Stéphane Bretagne; Jean-Charles Gantier; Dea Garcia-Hermoso; Olivier Lortholary; Françoise Dromer; Eric Dannaoui
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

7.  Carbon assimilation profiles as a tool for identification of zygomycetes.

Authors:  Patrick Schwarz; Olivier Lortholary; Françoise Dromer; Eric Dannaoui
Journal:  J Clin Microbiol       Date:  2007-02-28       Impact factor: 5.948

8.  Combination liposomal amphotericin B, posaconazole and oral amphotericin B for treatment of gastrointestinal Mucorales in an immunocompromised patient.

Authors:  Anthony Anderson; Dayna McManus; Sarah Perreault; Ying-Chun Lo; Stuart Seropian; Jeffrey E Topal
Journal:  Med Mycol Case Rep       Date:  2017-05-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.